Replimune Group Analyst Ratings
Replimune Group Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 339.16% | HC Wainwright & Co. | $50 → $48 | Maintains | Buy |
| 11/08/2023 | 375.75% | Wedbush | → $52 | Reiterates | Outperform → Outperform |
| 08/07/2023 | 357.46% | HC Wainwright & Co. | $51 → $50 | Maintains | Buy |
| 08/01/2023 | 366.61% | HC Wainwright & Co. | → $51 | Reiterates | Buy → Buy |
| 06/15/2023 | 357.46% | JP Morgan | $38 → $50 | Maintains | Overweight |
| 06/08/2023 | 366.61% | HC Wainwright & Co. | → $51 | Reiterates | Buy → Buy |
| 06/07/2023 | 375.75% | Wedbush | → $52 | Reiterates | Outperform → Outperform |
| 06/07/2023 | 448.95% | EF Hutton | → $60 | Reiterates | Buy → Buy |
| 06/05/2023 | 366.61% | HC Wainwright & Co. | $50 → $51 | Maintains | Buy |
| 06/05/2023 | 448.95% | EF Hutton | → $60 | Reiterates | Buy → Buy |
| 05/26/2023 | 448.95% | EF Hutton | → $60 | Reiterates | Buy → Buy |
| 05/22/2023 | 375.75% | Wedbush | → $52 | Reiterates | Outperform → Outperform |
| 04/17/2023 | 302.56% | Piper Sandler | → $44 | Assumes | → Overweight |
| 02/10/2023 | 357.46% | HC Wainwright & Co. | $48 → $50 | Reiterates | → Buy |
| 01/05/2023 | 448.95% | EF Hutton | → $60 | Initiates Coverage On | → Buy |
| 12/12/2022 | 540.44% | BMO Capital | $40 → $70 | Maintains | Outperform |
| 12/07/2022 | 211.07% | SVB Leerink | $30 → $34 | Maintains | Outperform |
| 11/04/2022 | 339.16% | HC Wainwright & Co. | $60 → $48 | Maintains | Buy |
| 10/14/2022 | 265.97% | BMO Capital | $30 → $40 | Maintains | Outperform |
| 10/03/2022 | 174.47% | SVB Leerink | $37 → $30 | Maintains | Outperform |
| 08/16/2022 | 293.41% | Piper Sandler | $44 → $43 | Maintains | Overweight |
| 08/05/2022 | 238.52% | SVB Leerink | $48 → $37 | Maintains | Outperform |
| 05/24/2022 | 375.75% | Wedbush | $59 → $52 | Maintains | Outperform |
| 05/20/2022 | 339.16% | SVB Leerink | $49 → $48 | Maintains | Outperform |
| 04/04/2022 | 256.82% | JP Morgan | $47 → $39 | Maintains | Overweight |
| 03/18/2022 | 174.47% | BMO Capital | $51 → $30 | Maintains | Outperform |
| 11/19/2021 | 375.75% | Piper Sandler | → $52 | Initiates Coverage On | → Overweight |
| 08/23/2021 | 348.31% | SVB Leerink | $55 → $49 | Maintains | Outperform |
| 08/09/2021 | 403.2% | SVB Leerink | $56 → $55 | Maintains | Outperform |
| 02/05/2021 | 448.95% | HC Wainwright & Co. | $58 → $60 | Maintains | Buy |
| 02/04/2021 | 412.35% | SVB Leerink | $57 → $56 | Maintains | Outperform |
| 11/17/2020 | 448.95% | BTIG | → $60 | Initiates Coverage On | → Buy |
| 11/10/2020 | 430.65% | HC Wainwright & Co. | $54 → $58 | Maintains | Buy |
| 11/06/2020 | 421.5% | BMO Capital | $51 → $57 | Maintains | Outperform |
| 10/15/2020 | 366.61% | BMO Capital | $40 → $51 | Maintains | Outperform |
| 10/15/2020 | 394.05% | HC Wainwright & Co. | $25 → $54 | Upgrades | Neutral → Buy |
| 10/15/2020 | 302.56% | SVB Leerink | $27 → $44 | Maintains | Outperform |
| 08/07/2020 | 147.03% | SVB Leerink | $25 → $27 | Maintains | Outperform |
| 07/01/2020 | 128.73% | HC Wainwright & Co. | → $25 | Downgrades | Buy → Neutral |
| 06/04/2020 | 128.73% | HC Wainwright & Co. | $24 → $25 | Maintains | Buy |
| 05/05/2020 | 92.13% | Barclays | → $21 | Initiates Coverage On | → Overweight |
| 01/21/2020 | 119.58% | HC Wainwright & Co. | $26 → $24 | Maintains | Buy |
| 09/04/2019 | 82.98% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
| 07/23/2019 | 156.18% | Chardan Capital | → $28 | Initiates Coverage On | → Buy |
| 07/12/2019 | 137.88% | JP Morgan | $27 → $26 | Upgrades | Neutral → Overweight |
| 07/08/2019 | 137.88% | HC Wainwright & Co. | → $26 | Initiates Coverage On | → Buy |
| 04/25/2019 | 119.58% | Wedbush | → $24 | Initiates Coverage On | → Outperform |
| 01/23/2019 | — | JP Morgan | Downgrades | Overweight → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/13/2023 | 339.16% | HC Wainwright & Co. | 50 美元 → 48 美元 | 維護 | 買 |
| 11/08/2023 | 375.75% | Wedbush | → 52 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
| 08/07/2023 | 357.46% | HC Wainwright & Co. | 51 美元 → 50 美元 | 維護 | 買 |
| 08/01/2023 | 366.61% | HC Wainwright & Co. | → 51 美元 | 重申 | 購買 → 購買 |
| 06/15/2023 | 357.46% | 摩根大通 | 38 美元 → 50 美元 | 維護 | 超重 |
| 06/08/2023 | 366.61% | HC Wainwright & Co. | → 51 美元 | 重申 | 購買 → 購買 |
| 06/07/2023 | 375.75% | Wedbush | → 52 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
| 06/07/2023 | 448.95% | EF Hutton | → 60 美元 | 重申 | 購買 → 購買 |
| 06/05/2023 | 366.61% | HC Wainwright & Co. | 50 美元 → 51 美元 | 維護 | 買 |
| 06/05/2023 | 448.95% | EF Hutton | → 60 美元 | 重申 | 購買 → 購買 |
| 05/26/2023 | 448.95% | EF Hutton | → 60 美元 | 重申 | 購買 → 購買 |
| 05/22/2023 | 375.75% | Wedbush | → 52 美元 | 重申 | 跑贏大盤 → 跑贏大盤 |
| 04/17/2023 | 302.56% | 派珀·桑德勒 | → 44 美元 | 假設 | → 超重 |
| 02/10/2023 | 357.46% | HC Wainwright & Co. | 48 美元 → 50 美元 | 重申 | → 購買 |
| 01/05/2023 | 448.95% | EF Hutton | → 60 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2022 年 12 月 12 日 | 540.44% | BMO Capital | 40 美元 → 70 美元 | 維護 | 跑贏大盤 |
| 2022 年 7 月 12 日 | 211.07% | SVB Leerink | 30 美元 → 34 美元 | 維護 | 跑贏大盤 |
| 2022 年 4 月 11 日 | 339.16% | HC Wainwright & Co. | 60 美元 → 48 美元 | 維護 | 買 |
| 2022 年 10 月 14 日 | 265.97% | BMO Capital | 30 美元 → 40 美元 | 維護 | 跑贏大盤 |
| 2022 年 3 月 10 日 | 174.47% | SVB Leerink | 37 美元 → 30 美元 | 維護 | 跑贏大盤 |
| 08/16/2022 | 293.41% | 派珀·桑德勒 | 44 美元 → 43 美元 | 維護 | 超重 |
| 08/05/2022 | 238.52% | SVB Leerink | 48 美元 → 37 美元 | 維護 | 跑贏大盤 |
| 2022 年 5 月 24 日 | 375.75% | Wedbush | 59 美元 → 52 美元 | 維護 | 跑贏大盤 |
| 05/20/2022 | 339.16% | SVB Leerink | 49 美元 → 48 美元 | 維護 | 跑贏大盤 |
| 2022 年 4 月 4 日 | 256.82% | 摩根大通 | 47 美元 → 39 美元 | 維護 | 超重 |
| 03/18/2022 | 174.47% | BMO Capital | 51 美元 → 30 美元 | 維護 | 跑贏大盤 |
| 11/19/2021 | 375.75% | 派珀·桑德勒 | → 52 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 08/23/2021 | 348.31% | SVB Leerink | 55 美元 → 49 美元 | 維護 | 跑贏大盤 |
| 2021 年 9 月 8 日 | 403.2% | SVB Leerink | 56 美元 → 55 美元 | 維護 | 跑贏大盤 |
| 02/05/2021 | 448.95% | HC Wainwright & Co. | 58 美元 → 60 美元 | 維護 | 買 |
| 02/04/2021 | 412.35% | SVB Leerink | 57 美元 → 56 美元 | 維護 | 跑贏大盤 |
| 2020 年 11 月 17 日 | 448.95% | BTIG | → 60 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/10/2020 | 430.65% | HC Wainwright & Co. | 54 美元 → 58 美元 | 維護 | 買 |
| 11/06/2020 | 421.5% | BMO Capital | 51 美元 → 57 美元 | 維護 | 跑贏大盤 |
| 2020 年 10 月 15 日 | 366.61% | BMO Capital | 40 美元 → 51 美元 | 維護 | 跑贏大盤 |
| 2020 年 10 月 15 日 | 394.05% | HC Wainwright & Co. | 25 美元 → 54 美元 | 升級 | 中性 → 買入 |
| 2020 年 10 月 15 日 | 302.56% | SVB Leerink | 27 美元 → 44 美元 | 維護 | 跑贏大盤 |
| 08/07/2020 | 147.03% | SVB Leerink | 25 美元 → 27 美元 | 維護 | 跑贏大盤 |
| 07/01/2020 | 128.73% | HC Wainwright & Co. | → 25 美元 | 降級 | 買入 → 中性 |
| 06/04/2020 | 128.73% | HC Wainwright & Co. | 24 美元 → 25 美元 | 維護 | 買 |
| 05/05/2020 | 92.13% | 巴克萊 | → 21 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 2020 年 1 月 21 日 | 119.58% | HC Wainwright & Co. | 26 美元 → 24 美元 | 維護 | 買 |
| 09/04/2019 | 82.98% | 羅斯資本 | → 20 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 07/23/2019 | 156.18% | 查丹資本 | → 28 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 07/12/2019 | 137.88% | 摩根大通 | 27 美元 → 26 美元 | 升級 | 中性 → 超重 |
| 07/08/2019 | 137.88% | HC Wainwright & Co. | → 26 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/25/2019 | 119.58% | Wedbush | → 24 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 2019 年 1 月 23 日 | — | 摩根大通 | 降級 | 超重 → 中性 |
What is the target price for Replimune Group (REPL)?
Replimune Group（REPL）的目標價格是多少？
The latest price target for Replimune Group (NASDAQ: REPL) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $48.00 expecting REPL to rise to within 12 months (a possible 339.16% upside). 17 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月13日公佈了Replimune集團（納斯達克股票代碼：REPL）的最新目標股價。該分析公司將目標股價定爲48.00美元，預計REPL將在12個月內升至12個月內（可能上漲339.16％）。去年有17家分析公司公佈了評級。
What is the most recent analyst rating for Replimune Group (REPL)?
分析師對Replimune Group（REPL）的最新評級是多少？
The latest analyst rating for Replimune Group (NASDAQ: REPL) was provided by HC Wainwright & Co., and Replimune Group maintained their buy rating.
HC Wainwright & Co. 提供了Replimune Group（納斯達克股票代碼：REPL）的最新分析師評級，Replimune Group維持其買入評級。
When is the next analyst rating going to be posted or updated for Replimune Group (REPL)?
Replimune Group（REPL）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Replimune Group的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Replimune Group的最新評級是在2023年11月13日發佈的，因此您應該預計下一個評級將在2024年11月13日左右公佈。
Is the Analyst Rating Replimune Group (REPL) correct?
分析師評級 Replimune Group（REPL）是否正確？
While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a maintained with a price target of $50.00 to $48.00. The current price Replimune Group (REPL) is trading at is $10.93, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Replimune Group（REPL）評級維持不變，目標股價爲50.00美元至48.00美元。Replimune Group（REPL）目前的交易價格爲10.93美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。